» Articles » PMID: 34453061

Clinical Outcomes of Frozen Autograft Reconstruction for the Treatment of Primary Bone Sarcoma in Adolescents and Young Adults

Overview
Journal Sci Rep
Specialty Science
Date 2021 Aug 28
PMID 34453061
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Age affects the clinical outcomes of cancer treatment, including those for bone sarcoma. Successful reconstruction using frozen autograft after excision of bone sarcoma has been reported; however, little is known about the clinical outcomes of frozen autograft reconstruction according to age. The purpose was to evaluate the clinical outcomes of the frozen autograft reconstruction focusing on skeletally mature adolescents and young adults (AYAs) that was 15 to 39 years of age. A total of 37 AYA patients with primary bone sarcoma on the appendicular skeleton were enrolled in this study. The mean follow-up period was 89 months. The graft survival (GS), overall survival (OS), recurrence-free survival (RFS), complications and the function were retrospectively evaluated using medical records. The 10-year GS, OS, and RFS rates were 76%, 84%, and 79%, respectively. Bone union was achieved with a rate of 94% within 1 year after surgery, and nonunion (n = 1) and fracture (n = 2) were infrequently observed. Graft removal was performed in 7 cases, and the most common reason for the removal was infection (n = 5). The Musculoskeletal Tumor Society score was excellent in 23 cases of the available 29 cases. Frozen autograft reconstruction for AYAs showed excellent clinical outcomes, although the long-term follow-up is required.

Citing Articles

Failure Modes in Orthopedic Oncologic Reconstructive Surgery: A Review of Imaging Findings and Failure Rates.

Shah A, Cardoso F, Souza F, Montreuil J, Pretell-Mazzini J, Temple H Curr Oncol. 2024; 31(10):6245-6266.

PMID: 39451769 PMC: 11506460. DOI: 10.3390/curroncol31100465.


Complications and Outcome of Bone Sarcoma Patients with Limb Salvage using Liquid Nitrogen-treated Bone for Reconstruction.

Farooq M, Shafiq M, Ali S, Rafi I J Cancer Allied Spec. 2024; 10(1):543.

PMID: 38259680 PMC: 10793719. DOI: 10.37029/jcas.v10i1.543.


A comparative study of reconstruction modalities after knee joint-preserving tumor resection: reconstruction with a custom-made endoprosthesis versus reconstruction with a liquid nitrogen-inactivated autologous bone graft.

Li Y, Xu H, Shan H, Ma K, Liu W, Niu X J Orthop Surg Res. 2023; 18(1):908.

PMID: 38031112 PMC: 10685649. DOI: 10.1186/s13018-023-04402-3.


Surgical Site Infection after Bone Tumor Surgery: Risk Factors and New Preventive Techniques.

Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H Cancers (Basel). 2022; 14(18).

PMID: 36139686 PMC: 9497226. DOI: 10.3390/cancers14184527.


Hemiarthroplasty of Pedicle-Frozen Proximal Tibia for Primary Malignant Bone Tumours.

Hindiskere S, Rajan S, Pal U, Dixit P, Varma V, Chinder P Indian J Orthop. 2022; 56(7):1285-1290.

PMID: 35813537 PMC: 9232691. DOI: 10.1007/s43465-022-00658-9.


References
1.
Tsuchiya H, Nishida H, Srisawat P, Shirai T, Hayashi K, Takeuchi A . Pedicle frozen autograft reconstruction in malignant bone tumors. J Orthop Sci. 2010; 15(3):340-9. DOI: 10.1007/s00776-010-1458-0. View

2.
He F, Zhang W, Shen Y, Yu P, Bao Q, Wen J . Effects of resection margins on local recurrence of osteosarcoma in extremity and pelvis: Systematic review and meta-analysis. Int J Surg. 2016; 36(Pt A):283-292. DOI: 10.1016/j.ijsu.2016.11.016. View

3.
Onari I, Hayashi M, Ozaki N, Tsuchiya H . Vitreous preservation of articular cartilage from cryoinjury in rabbits. Cryobiology. 2012; 65(2):98-103. DOI: 10.1016/j.cryobiol.2012.05.006. View

4.
Pinzone M, Berretta M, Doerr H, Nunnari G, Cacopardo B . The complexity of aging: cancer risk among elderly people and infectious risk among those with cancer. Anticancer Agents Med Chem. 2013; 13(9):1444-8. DOI: 10.2174/18715206113136660346. View

5.
Pritz T, Weinberger B, Grubeck-Loebenstein B . The aging bone marrow and its impact on immune responses in old age. Immunol Lett. 2014; 162(1 Pt B):310-5. DOI: 10.1016/j.imlet.2014.06.016. View